Chemical Structure : GSK-2033
CAS No.: 1221277-90-2
货号: PC-63084Not For Human Use, Lab Use Only.
GSK-2033 (GSK2033) is the first potent, cell-active LXR antagonist with binding pIC50 of 7.0/7.5 for LXRα/LXRβ, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1180 | In stock | |
10 mg | ¥1780 | In stock | |
25 mg | ¥2780 | In stock | |
50 mg | ¥4580 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
GSK-2033 (GSK2033) is the first potent, cell-active LXR antagonist with binding pIC50 of 7.0/7.5 for LXRα/LXRβ, respectively.
GSK-2033 suppresses GC-induced gluconeogenic gene expression without affecting immune-responsive GR target genes.
GSK-2033 displays unexpected activity in the mouse NAFLD model.
分子量 | 591.66 | |
分子式 | C29H28F3NO5S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2,4,6-Trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]benzenesulfonamide |
1. Zuercher WJ, et al. J Med Chem. 2010 Apr 22;53(8):3412-6.
2. Griffett K, et al. Biochem Biophys Res Commun. 2016 Oct 21;479(3):424-428.
3. Patel R, et al. Endocrinology. 2017 Apr 1;158(4):1034-1047.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright